Cell Therapy

How Is Tech Shaping the Analytical Instrument Industry?
Research & Development How Is Tech Shaping the Analytical Instrument Industry?

The seamless integration of technology into the fabric of scientific research has brought about a seminal shift in the analytical instrument industry. Key industry players have long recognized that innovation is not just a buzzword but the fundamental driver of growth and efficiency in the lab.

S&P 500 Surge Signals Bright End; Biopharma Stocks Shine
Research & Development S&P 500 Surge Signals Bright End; Biopharma Stocks Shine

The financial markets have recently witnessed a significant uptick, particularly focusing on the robust performance of the S&P 500 index. With a history of early gains often translating into positive year-end outcomes, the current rise of over 10% within the first 100 trading days has set a hopeful

Revolutionizing Medicine with Cell Therapy Breakthroughs
Research & Development Revolutionizing Medicine with Cell Therapy Breakthroughs

In the ever-evolving landscape of medical treatments, cell therapy emerges as a vivid illustration of how cutting-edge science can unlock new horizons in healthcare. This article delves into the transformative world of cell therapy, highlighting its current state, potential, and the multifaceted

Is Biotech Shifting From Oncology to Autoimmune Research?
Research & Development Is Biotech Shifting From Oncology to Autoimmune Research?

The biotech industry is at a crossroads, grappling with the challenges and expectations set by cell therapies. Oncology-focused treatments that once held great promise are now facing a reality check, prompting many companies to reevaluate their focus on autoimmune diseases. As expectations align

Merck to Buy Mirus Bio in $600M Deal to Boost Gene Therapy
Biotech & Bioprocessing Merck to Buy Mirus Bio in $600M Deal to Boost Gene Therapy

In a significant expansion of its life sciences portfolio, global science and technology leader Merck has announced a definitive agreement to purchase Mirus Bio for a staggering $600 million. Mirus Bio, a pioneering life sciences company, specializes in developing transfection reagents, a

Is CAR T-cell Therapy the Future of Cancer Treatment?
Research & Development Is CAR T-cell Therapy the Future of Cancer Treatment?

The battle against cancer is one that has engaged the global medical community for decades, and with the emergence of Chimeric Antigen Receptor (CAR) T-cell therapy, we stand on the precipice of a significant revolution in the way cancer is treated. This immunotherapy transforms a patient's own

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later